The ultimate shared pathway of eGC damage, particularly in bacterial sepsis and COVID-19, seems to involve the activation and release of heparanase (HPSE), a heparan sulphate (HS)-degrading enzyme that is unique to mammals and breaks down HS chains from HS proteoglycans found in the glycocalyx [9–11]. Here, HPSE is linked to COVID-19.